Related Experiment Videos
Pathogenesis of chronic allograft rejection
Simone A Joosten1, Cees van Kooten, Leendert C Paul
1Department of Nephrology, C3P, Leiden University Medical Centre, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands. s.a.joosten@lumc.nl
Summary
Chronic allograft nephropathy (CAN) causes renal transplant loss through fibrotic tissue replacement. Understanding antigen presentation and antibody production is key to managing chronic rejection (CR) and improving graft survival.
Area of Science:
- Nephrology
- Immunology
- Transplantation Science
Background:
- Chronic allograft nephropathy (CAN) is a leading cause of renal transplant failure.
- CAN involves graft dysfunction and fibrotic tissue replacement, with unclear multifactorial pathogenesis.
- Alloantigen-dependent mechanisms are critical in chronic rejection (CR), despite advances in immunosuppression.
Purpose of the Study:
- To review the role of antigen presentation in CR development.
- To focus on antibody production against HLA and non-HLA antigens in CR.
- To elucidate mechanisms contributing to renal transplant loss.
Main Methods:
- Literature review focusing on antigen presentation pathways (direct and indirect).
- Analysis of antibody-mediated mechanisms in chronic rejection.
- Discussion of factors influencing graft survival post-transplantation.
Main Results:
- Direct and indirect antigen presentation are crucial in CR pathogenesis.
- Antibodies against HLA and non-HLA antigens significantly influence CR.
- Current immunosuppressants have limited impact on CR compared to acute rejection.
Conclusions:
- Understanding antigen presentation and antibody responses is vital for combating CR.
- Targeting these pathways may improve long-term renal allograft survival.
- Further research is needed to develop effective strategies against CAN.